BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17367830)

  • 1. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus.
    Alt N; Kley S; Tschuor F; Zapf J; Reusch CE
    Res Vet Sci; 2007 Dec; 83(3):331-5. PubMed ID: 17367830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
    Hall TD; Mahony O; Rozanski EA; Freeman LM
    J Feline Med Surg; 2009 Feb; 11(2):125-30. PubMed ID: 18835801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of four methods used to measure plasma insulin-like growth factor 1 concentrations in healthy cats and cats with diabetes mellitus or other diseases.
    Tschuor F; Zini E; Schellenberg S; Wenger M; Boretti FS; Reusch CE
    Am J Vet Res; 2012 Dec; 73(12):1925-31. PubMed ID: 23176419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
    Alt N; Kley S; Haessig M; Reusch CE
    J Am Vet Med Assoc; 2007 Apr; 230(7):1011-7. PubMed ID: 17397339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats.
    Starkey SR; Tan K; Church DB
    J Feline Med Surg; 2004 Jun; 6(3):149-55. PubMed ID: 15135351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy in cats with diabetes mellitus.
    Moise NS; Reimers TJ
    J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus.
    Reusch CE; Kley S; Casella M; Nelson RW; Mol J; Zapf J
    Vet Rec; 2006 Feb; 158(6):195-200. PubMed ID: 16474053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus.
    Strage EM; Sundberg M; Holst BS; Andersson Franko M; Ramström M; Fall T; Lewitt M
    J Vet Intern Med; 2018 Sep; 32(5):1579-1590. PubMed ID: 30112786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food intake and blood glucose in normal and diabetic cats fed ad libitum.
    Martin GJ; Rand JS
    J Feline Med Surg; 1999 Dec; 1(4):241-51. PubMed ID: 11714241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum fructosamine concentration as an index of blood glucose control in cats with diabetes mellitus.
    Kaneko JJ; Kawamoto M; Heusner AA; Feldman EC; Koizumi I
    Am J Vet Res; 1992 Oct; 53(10):1797-801. PubMed ID: 1456523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus.
    Bennett N; Greco DS; Peterson ME; Kirk C; Mathes M; Fettman MJ
    J Feline Med Surg; 2006 Apr; 8(2):73-84. PubMed ID: 16275041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasma islet amyloid polypeptide and serum glucose and insulin concentrations in nondiabetic cats classified by body condition score and in cats with naturally occurring diabetes mellitus.
    Henson MS; Hegstad-Davies RL; Wang Q; Hardy RM; Armstrong PJ; Jordan K; Johnson KH; O'Brien TD
    Am J Vet Res; 2011 Aug; 72(8):1052-8. PubMed ID: 21801062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fructosamine concentration in cats with overt hyperthyroidism.
    Reusch CE; Tomsa K
    J Am Vet Med Assoc; 1999 Nov; 215(9):1297-300. PubMed ID: 10553441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline diabetes mellitus: diagnosis, treatment, and monitoring.
    Rios L; Ward C
    Compend Contin Educ Vet; 2008 Dec; 30(12):626-39; quiz 639-40. PubMed ID: 19140103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment clinical and laboratory evaluation of cats with diabetes mellitus: 104 cases (1992-1994).
    Crenshaw KL; Peterson ME
    J Am Vet Med Assoc; 1996 Sep; 209(5):943-9. PubMed ID: 8790546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of diabetes mellitus in five cats with somatotrophic abnormalities.
    Norman EJ; Mooney CT
    J Feline Med Surg; 2000 Dec; 2(4):183-90. PubMed ID: 11716617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound hyperglycemia following overdosing of insulin in cats with diabetes mellitus.
    McMillan FD; Feldman EC
    J Am Vet Med Assoc; 1986 Jun; 188(12):1426-31. PubMed ID: 3528096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.